• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通人群中罗马 IV 肠易激综合征患者的医疗保健利用情况。

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.

机构信息

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Academic Unit of Gastroenterology & Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

出版信息

United European Gastroenterol J. 2021 Dec;9(10):1178-1188. doi: 10.1002/ueg2.12153. Epub 2021 Oct 1.

DOI:10.1002/ueg2.12153
PMID:34599559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8672084/
Abstract

BACKGROUND

Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms for healthcare seeking behaviours in this patient group are poorly understood.

OBJECTIVE

To describe healthcare utilization and identify factors associated with seeking healthcare amongst IBS subjects in the general population.

METHODS

An internet survey was completed by 6,300 individuals equally distributed between United States, United Kingdom and Canada. The Rome IV diagnostic questionnaire was used to identify subjects with IBS. Data on demographics, medical history, gastrointestinal (GI) and non-GI symptoms, quality of life and health care consumption was collected.

RESULTS

A total of 5,931 subjects were included; 274 (4.6%) IBS subjects and 5657 (95.3%) non-IBS controls. IBS subjects reported more doctor consultations for both GI and other health problems as well as increased use of medication and rate of abdominal surgery (appendectomy excluded). Having healthcare insurance or access to free public healthcare (adjusted odds ratio (AOR) 4.49, 95% confidence interval (CI) 1.31-15.44), followed by high frequency of bloating (AOR 2.65, 95% CI 1.42-4.93) and increasing age (AOR 1.02, 95% CI 1.01-1.05) were found to be independently associated with being an IBS consulter while doctor-diagnosed IBS subjects were more likely to be female and to report abdominal pain as their most bothersome GI symptom than other consulters with IBS.

CONCLUSION

IBS subjects have higher healthcare utilization than non-IBS controls, medication use and abdominal surgery included. Furthermore, consulters with and without an IBS diagnosis differ in sex distribution and symptom profiles. Hence, awareness of the possibility of unnecessary medical and surgical treatment in IBS subjects and a sex-related diagnostic bias by doctors is warranted.

摘要

背景

肠易激综合征(IBS)在全球范围内高发,但该患者群体寻求医疗保健的机制尚不清楚。

目的

描述普通人群中 IBS 患者的医疗保健利用情况,并确定与寻求医疗保健相关的因素。

方法

通过互联网对 6300 名来自美国、英国和加拿大的个体进行了一项调查。采用罗马 IV 诊断问卷来识别 IBS 患者。收集了人口统计学、病史、胃肠道(GI)和非 GI 症状、生活质量和医疗保健消费的数据。

结果

共纳入 5931 名受试者;274 名(4.6%)IBS 患者和 5657 名(95.3%)非 IBS 对照者。IBS 患者报告他们因 GI 和其他健康问题看医生的次数更多,并且使用药物和腹部手术的频率更高(不包括阑尾切除术)。有医疗保险或可以获得免费公共医疗保健(调整后的优势比(AOR)4.49,95%置信区间(CI)1.31-15.44),其次是腹胀的高频率(AOR 2.65,95%CI 1.42-4.93)和年龄的增加(AOR 1.02,95%CI 1.01-1.05)与成为 IBS 就诊者独立相关,而医生诊断为 IBS 的患者更有可能是女性,并且报告腹痛是他们最困扰的 GI 症状,而不是其他 IBS 就诊者。

结论

IBS 患者的医疗保健利用率高于非 IBS 对照组,包括药物使用和腹部手术。此外,有和没有 IBS 诊断的就诊者在性别分布和症状特征上存在差异。因此,需要意识到 IBS 患者存在不必要的医疗和手术治疗的可能性,以及医生存在与性别相关的诊断偏见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/b9eff7755c15/UEG2-9-1178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/eac6eda5cace/UEG2-9-1178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/314a11e4f756/UEG2-9-1178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/b9eff7755c15/UEG2-9-1178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/eac6eda5cace/UEG2-9-1178-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/314a11e4f756/UEG2-9-1178-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5720/8672084/b9eff7755c15/UEG2-9-1178-g001.jpg

相似文献

1
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.普通人群中罗马 IV 肠易激综合征患者的医疗保健利用情况。
United European Gastroenterol J. 2021 Dec;9(10):1178-1188. doi: 10.1002/ueg2.12153. Epub 2021 Oct 1.
2
Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.美国、加拿大和英国成年人中罗马 IV 功能性肠病的流行情况。
Gastroenterology. 2020 Apr;158(5):1262-1273.e3. doi: 10.1053/j.gastro.2019.12.021. Epub 2020 Jan 7.
3
Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study.IBS 患者亚组的特点是具有特定的、可重复的胃肠道和非胃肠道症状谱,并报告在医疗保健利用方面存在差异:一项基于人群的研究。
Neurogastroenterol Motil. 2019 Jan;31(1):e13483. doi: 10.1111/nmo.13483. Epub 2018 Nov 4.
4
Prevalence and impact of self-reported irritable bowel symptoms in the general population.一般人群中自报的肠易激综合征症状的流行情况及其影响。
United European Gastroenterol J. 2019 Mar;7(2):307-315. doi: 10.1177/2050640618821804. Epub 2018 Dec 22.
5
Why do subjects with irritable bowel syndrome seek health care for their symptoms?为什么肠易激综合征患者会因其症状寻求医疗护理?
Scand J Gastroenterol. 2007 Oct;42(10):1194-203. doi: 10.1080/00365520701320455.
6
Gender difference on the symptoms, health-seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan.肠易激综合征患者在症状、就医行为、社会影响及睡眠质量方面的性别差异:基于罗马II标准对台湾健康成年人群的调查
Aliment Pharmacol Ther. 2005 Jun 15;21(12):1497-505. doi: 10.1111/j.1365-2036.2005.02512.x.
7
Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.希腊北部肠易激综合征患者的患病率、肠习惯亚型和就医行为。
Eur J Gastroenterol Hepatol. 2009 Feb;21(2):183-9. doi: 10.1097/MEG.0b013e328312eb97.
8
Comorbidity and use of health-care services among irritable bowel syndrome sufferers.肠易激综合征患者的合并症及医疗服务利用情况
Scand J Gastroenterol. 2007 Jul;42(7):799-806. doi: 10.1080/00365520601113927.
9
The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.重叠 Rome IV 诊断功能性胃肠疾病对躯体化、生活质量和医疗保健利用的影响:三个国家的横断面一般人群研究。
Am J Gastroenterol. 2018 Jan;113(1):86-96. doi: 10.1038/ajg.2017.421. Epub 2017 Nov 14.
10
Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.美国、加拿大和英国基于症状的罗马 IV 功能性消化不良的成年人的流行病学、临床特征及相关因素:一项横断面基于人群的研究。
Lancet Gastroenterol Hepatol. 2018 Apr;3(4):252-262. doi: 10.1016/S2468-1253(18)30003-7. Epub 2018 Feb 1.

引用本文的文献

1
The Role of the Nurse in the Management of Irritable Bowel Syndrome: A Narrative Review.护士在肠易激综合征管理中的作用:一项叙述性综述
Transl Med UniSa. 2023 Dec 22;25(1):28-37. doi: 10.37825/2239-9747.1043. eCollection 2023.
2
Results from a Cross-Sectional Observational Study Examining Irritable Bowel Syndrome Patients Six Months After Finishing Their Participation in the ViIBS Trial.一项横断面观察性研究的结果,该研究在完成 ViIBS 试验后 6 个月对肠易激综合征患者进行了检查。
Nutrients. 2024 Nov 15;16(22):3911. doi: 10.3390/nu16223911.
3
A Pharmacy-Based Observational Study of Digest-8 Dietary Supplement in a Consumer Healthcare Context.

本文引用的文献

1
Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.美国慢性症状性功能性肠病的流行病学负担和治疗:一项全国性分析。
Gastroenterology. 2021 Jan;160(1):88-98.e4. doi: 10.1053/j.gastro.2020.09.041. Epub 2020 Oct 1.
2
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.全球功能性胃肠病的流行情况和负担:罗马基金会全球研究结果。
Gastroenterology. 2021 Jan;160(1):99-114.e3. doi: 10.1053/j.gastro.2020.04.014. Epub 2020 Apr 12.
3
Management of Chronic Abdominal Distension and Bloating.
在消费者医疗保健背景下对Digest-8膳食补充剂进行的基于药房的观察性研究。
Glob Adv Integr Med Health. 2024 Jul 25;13:27536130241268240. doi: 10.1177/27536130241268240. eCollection 2024 Jan-Dec.
4
Synbiotics as Treatment for Irritable Bowel Syndrome: A Review.合生元治疗肠易激综合征的综述
Microorganisms. 2024 Jul 21;12(7):1493. doi: 10.3390/microorganisms12071493.
5
Effectiveness of a Balanced Nine-Strain Synbiotic in Primary-Care Irritable Bowel Syndrome Patients-A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial.一种平衡九菌共生元在初级保健肠易激综合征患者中的疗效:一项多中心、随机、双盲、安慰剂对照试验。
Nutrients. 2024 May 16;16(10):1503. doi: 10.3390/nu16101503.
6
What impact has the Centre of Research Excellence in Digestive Health made in the field of gastrointestinal health in Australia and internationally? Study protocol for impact evaluation using the FAIT framework.卓越研究中心在澳大利亚和国际上的胃肠道健康领域产生了什么影响?使用 FAIT 框架进行影响评估的研究方案。
BMJ Open. 2024 Mar 21;14(3):e076839. doi: 10.1136/bmjopen-2023-076839.
7
The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome.牛κ-酪蛋白糖巨肽在调节肠易激综合征微生物群和炎症反应中的作用
Nutrients. 2023 Sep 15;15(18):3991. doi: 10.3390/nu15183991.
8
Is C-section a risk factor for the early onset of irritable bowel syndrome?剖宫产是肠易激综合征早发的危险因素吗?
Med Pharm Rep. 2023 Apr;96(2):164-169. doi: 10.15386/mpr-2536. Epub 2023 Apr 27.
9
Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.多组学在腹痛和肠易激综合征的诊断评估和管理中的生物标志物方法:未来的方向。
Gut Microbes. 2023 Jan-Dec;15(1):2195792. doi: 10.1080/19490976.2023.2195792.
10
Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.肠脑互动障碍:在医学教育中高度普遍存在且负担沉重,但却未得到充分教授。
United European Gastroenterol J. 2022 Sep;10(7):736-744. doi: 10.1002/ueg2.12271. Epub 2022 Jul 3.
慢性腹胀的管理
Clin Gastroenterol Hepatol. 2021 Feb;19(2):219-231.e1. doi: 10.1016/j.cgh.2020.03.056. Epub 2020 Apr 1.
4
Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders.精神药物、抗抑郁药与内脏镇痛药在功能性胃肠病中的应用
Curr Gastroenterol Rep. 2018 Nov 5;20(12):58. doi: 10.1007/s11894-018-0664-3.
5
Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.了解腹泻型肠易激综合征的症状负担及患者态度:患者与医疗保健专业人员调查结果
United European Gastroenterol J. 2018 Nov;6(9):1417-1427. doi: 10.1177/2050640618787648. Epub 2018 Jul 9.
6
Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.肠易激综合征(IBS)患者的工作效率和活动能力受损:一个多方面的问题。
Am J Gastroenterol. 2018 Oct;113(10):1540-1549. doi: 10.1038/s41395-018-0262-x. Epub 2018 Sep 25.
7
Health problems associated with irritable bowel syndrome: analysis of a primary care registry.与肠易激综合征相关的健康问题:一项初级保健登记研究分析。
Aliment Pharmacol Ther. 2018 May;47(10):1349-1357. doi: 10.1111/apt.14612. Epub 2018 Mar 24.
8
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.功能性胃肠病的神经调节剂(肠脑相互作用障碍):罗马基金会工作组报告。
Gastroenterology. 2018 Mar;154(4):1140-1171.e1. doi: 10.1053/j.gastro.2017.11.279. Epub 2017 Dec 22.
9
The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.重叠 Rome IV 诊断功能性胃肠疾病对躯体化、生活质量和医疗保健利用的影响:三个国家的横断面一般人群研究。
Am J Gastroenterol. 2018 Jan;113(1):86-96. doi: 10.1038/ajg.2017.421. Epub 2017 Nov 14.
10
Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.腹胀和腹部膨隆:旧观念与新知识。
Am J Gastroenterol. 2017 Aug;112(8):1221-1231. doi: 10.1038/ajg.2017.129. Epub 2017 May 16.